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Abstract  
 Diabetic complications are considered a public concern on global 
level and have their negative impacts on patients. The main objectives of the 
present study were to determine the prevalence of diabetic complications 
among a sample of diabetics in Royal Medical Services and to conclude the 
appropriate recommendations to reduce the effects of diabetic complications. 
The method of choice involved a retrospective design and 392 files of 
diabetic patients were reviewed. Study findings showed that the prevalence 
of diabetic neuropathy was 43%, hypertension 42%, diabetic foot ulcer 9%, 
glaucoma 48%, and heart disease 25%. Predictors for diabetic neuropathy 
were the level of HbA1C (p=0.015), and gender (p=0.018), while the 
predictors for hypertension were duration of DM (p=0.000) and age 
(p=0.000). The predictors of foot ulcer included  the level of HbA1C 
(p=0.013), and the use of metformin (p=0.026). Glaucoma was predicted by 
duration of DM (p=0.002), and gender (p=0.017). Heart disease was 
predicted by duration of DM (p=0.003), gender (p=0.041), and age 
(p=0.000). Taken together, diabetic complications are prevalent on global 
level and in our settings which implies that the therapeutic options of DM are 
still far from their ultimate goals. we recommend adopting of more effective 
monitoring systems for screening diabetics, particularly those who are 
expected to develop diabetes. We also recommend to activate the roles of 
clinical pharmacist to raise the awareness level about diabetic complications 
among the public. 
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Introduction  
 It has been indicated through several studies that diabetes mellitus 
(DM) has increased prevalence on the global level, and DM was regarded as 
a conformational disease (Dobson, 1999; Soto, 2001; Mahdavifard et al., 
2016).  
      Diabetic complications are likely to develop as a result of having 
chronic hyperglycemia. On global level, diabetic complications have 
increased prevalence without accompanying effective treating options. It is 
highly accepted that both hyperglycemia and oxidative stress are triggering 
factors for the initiation of diabetic complications (Singh et al., 2013).  
      Salvotelli et al (2015) conducted a study to  determine the prevalence 
and clinical variables associated with diabetic neuropathy. Study findings 
showed that the prevalence of neuropathy in type 2 diabetes was about 30% 
when searched with clinical examination. It was also found that BMI, 
HbA1C and ankle/brachial index were predictors of the existence of 
neuropathy. Reviewing literature showed that the prevalence of diabetic 
neuropathy varied from 13% to 75% (Dyck and Dyck, 1999; Tapp et al., 
2003; Stratton et al., 2004; Ziegler et al., 2008; Van Acker et al., 2009).  
     Abougalambou and Abougalambou (2013) found that the prevalence 
of hypertension among Malaysian patients with type 2 diabetes was 92.4%. 
Diabetes is usually existing with hypertension and diabetics have increased 
prevalence of hypertension, and hypertensive patients have the tendency to 
develop type-2 diabetes (Sowers  et al., 2001; Wild et al., 2004). the 
prevalence of hypertension among diabetics varied among studies, as an 
example, Tseng (2006) reported that the prevalence of hypertension among 
Taiwanese population was 39%. 
     Diabetic foot disease is expected to increase in future because of the 
existence of predisposing factors to foot disease including peripheral 
neuropathy and vascular disease in more than 10% of people at the time of 
diagnosis of type 2 diabetes (UKPDS, 1998). It has been estimated that the 
annual incidence of foot ulceration is approximately 1–4%  (Bartus and 
Margolis, 2004), while the prevalence ranges from 4% to 10% (Boulton et 
al., 2005; Assaad et al., 2015). 
     Diabetes increases the risk of glaucoma through the induction of 
vascular constriction which, in turn, leads to increased intraocular pressure 
(Wilson and Martone, 1996; Johnson et al., 2005; Lauren et al., 2011). 
Diabetes also mediates the damage of glaucomatous optic nerve  (Kanamori 
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et al., 2004).  In their study, Lauren et al (2011) reported that the prevalence 
of glaucoma among patients with DM was 58%. 
 
Study objectives   
 The main objectives of the present study were to explore the 
prevalence of diabetic complications among diabetics, and to give 
recommendations according to guidelines for patients who did not achieve 
the therapeutic standards. 
 
Methods and subjects 
Study design and setting 
 This is a retrospective study and conducted at Royal Medical 
Services.  
 
Study sample  
 Study sample included 392 diabetic patients. 
 
Data collection 
 Files of patients with diabetics were reviewed to collect data. A 
working sheet was created for each patient which included: age, gender, 
duration of diabetes, the level of HbA1C, peripheral neuropathy, blood 
pressure, diabetic foot ulcer,  glaucoma, heart disease, and dyslipidemia. 
Files were accepted to be reviewed if all information were documented, and 
rejected if data required were missed.  
 
Statistical analysis  
 Data analysis was conducted using SPSS version 20. All variables 
were included and defined. Numerical variables including age, the level of 
HbA1C and duration of DM were presented as means and standard 
deviations, while categorical variables including gender, peripheral 
neuropathy, blood pressure, diabetic foot ulcer, glaucoma, heart disease, 
dyslipidemia, and the use of metformin were presented as frequencies and 
percentages. One Way Anova test was used to analyze data for factors 
influencing data diabetic complications. Significance was considered at 
alpha < 0.05 
 
Results  
General characteristics of participants 
 As it can be illustrated from table 1, the study included 392 diabetic 
patients. The mean age of participants is 56.18 years. The mean time of 
diabetes duration was about 8 years, the mean level of HbA1C was 7.5. 
About 53% of diabetics were females. Diabetic complications were exhibited 
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by diabetics such as peripheral neuropathy (about 43%), blood pressure 
(about 42%), diabetic foot ulcer (about 9%),  glaucoma (48%), heart disease 
(about 25%), and dyslipidemia (about 42%). About 84% of diabetic patients 
reported the receiving of metformin treatment. 
Table 1: General characteristics of participants 
Variable  Description  
Age (M+ SD) 56.18+ 9.51 years 
Duration of DM (M+ SD) 7.98+ 7.40 years 
HbA1C (M+ SD)  7.5+ 1.50 
Gender (N, %) 
Male  
Female  
 
183 (46.7%) 
209 (53.3%) 
Peripheral neuropathy  (N, %) 
Yes  
No  
 
168 (42.9%) 
224 (57.1%) 
Blood pressure (N, %) 
Yes  
No  
 
164 (41.8%) 
228 (58.2%) 
Diabetic foot ulcer (N, %) 
Yes  
No  
 
35 (8.9%) 
357 (91.1%) 
Glaucoma (N, %) 
Yes  
No  
 
188 (48%) 
204 (52%) 
Heart disease (N, %) 
Yes  
No   
 
97 (24.7%) 
295 (75.3%) 
Dyslipidemia (N, %) 
Yes  
No   
 
165 (42.1%) 
227 (57.9%) 
Metformin (N, %) 
Yes  
No  
 
331 (84.4%) 
61 (15.6%) 
 
The relationship between peripheral neuropathy and study variables 
 As shown in table 2, peripheral neuropathy in diabetic patients was 
influenced by gender (p=0.018) and the level of HbA1C (p=0.015). The 
other listed variables were not significant.  
 
 
 
 
Table 2: The relationship between peripheral neuropathy and study variables  
Variable  Sum of squares  Df  F  P value 
Duration of DM 196.012 1 3.604 0.058 
Gender  1.395 1 5.66 0.018 
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Age  46.164 1 0.510 0.476 
HbA1C 14.552 1 5.945 0.015 
Metformin  0.014 1 0.103 0.748 
 
The relationship between blood pressure and study variables 
 Table 3 showed that blood pressure in diabetic patients is under the 
influence of two variables duration of DM (p=0.000) and age (p=0.000). 
Table 3: The relationship between blood pressure and study variables 
Variable  Sum of squares  Df  F  P value 
Duration of DM 657.867 1 12.366 0.000 
Gender  0.747 1 3.007 0.084 
Age  1239.622 1 14.176 0.000 
HbA1C 4.129 1 1.668 0.197 
Metformin  0.024 1 0.184 0.669 
 
The relationship between diabetic foot ulcer and study variables 
 As shown in table 4, diabetic foot ulcer was significantly associated 
the level of HBA1C (p=0.013) and metformin (p=0.026). 
Table 4: The relationship between diabetic foot ulcer and study variables 
Variable  Sum of squares  Df  F  P value 
Duration of DM 0.107 1 0.002 0.965 
Gender  0.014 1 0.055 0.815 
Age  282.180 1 3.139 0.077 
HbA1C 15.142 1 6.190 0.013 
Metformin  0.651 1 4.99 0.026 
    
The relationship between glaucoma and study variables 
 As it can be seen from table 5, diabetic patients developed glaucoma, 
which was affected by duration of DM (p=0.002) and gender (p=0.017).  
Table 5: The relationship between glaucoma and study variables 
Variable  Sum of squares  Df  F  P value 
Duration of DM 502.154 1 9.369 0.002 
Gender  1.415 1 5.739 0.017 
Age  284.743 1 3.168 0.076 
HbA1C 6.111 1 2.475 0.117 
Metformin  0.031 1 0.236 0.628 
 
 
The relationship between heart disease and study variables 
 As shown in table 6, heart disease among diabetic patients was 
affected by duration of DM (p=0.003), gender (p=0.041), and the level of 
HbA1C (p=0.000).  
Table 6: The relationship between heart disease and study variables 
Variable  Sum of squares  Df  F  P value 
Duration of DM 468.910 1 8.735 0.003 
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Gender  1.041 1 4.206 0.041 
Age  2008.732 1 23.502 0.000 
HBA1C 0.518 1 0.209 0.648 
Metformin  0. 011 1 0.085 0.771 
 
The relationship between dyslipidemia and study variables 
 As shown in table 7, dyslipidemia was associated significantly with 
duration of DM (P=0.043). 
Table 7: The relationship between dyslipidemia and study variables 
Variable  Sum of squares  Df  F  P value 
Duration of DM 224.314 1 4.130 0.043 
Gender  0.043 1 0.172 0.678 
Age  254.840 1 2.833 0.093 
HbA1C 3.578 1 1.445 0.230 
Metformin  0.001 1 0.008 0.927 
 
Discussion 
    The present study was conducted in the light of the fact that the 
prevalence of diabetic complications has become increasing on the global 
level and in our local settings (Dobson, 1999; Soto, 2001; Mahdavifard et al., 
2016). The objectives of the current study were to determine the prevalence 
of diabetic complications among study participants and  to conclude the 
appropriate recommendations. 
    The data of the present study showed that the prevalence of 
peripheral neuropathy was about 43%. Both of gender (p=0.018) and the 
level of HbA1C (p=0.015) were predictors of the occurrence of peripheral 
neuropathy. The prevalence in our study is higher than that reported by 
Salvotelli et al (2015) who reported a prevalence of about 30% of peripheral 
neuropathy among patients with DM. Our  results also agreed with the 
results obtained by Salvotelli et al (2015) in which they reported that the 
level of HbA1C was a predictor of peripheral neuropathy. 
 The findings of the present study showed that the prevalence of 
hypertension was about 42%, and its predictors were duration of DM 
(p=0.000) and age (p=0.000). The prevalence of hypertension in our study 
was less than that reported by Abougalambou and Abougalambou (2013) 
who reported about 93% prevalence of hypertension among diabetics. The 
prevalence of hypertension among Taiwanese population was 39% as 
reported by Tseng (2006).  
    The prevalence of foot ulcer among diabetics was about 9%. This 
finding is consistent with other studies in which  the prevalence ranges from 
4% to 10% (Boulton et al., 2005; Assaad et al., 2015). 
 The prevalence of glaucoma in our study was 48%. We agree with 
other studies which reported a high prevalence of glaucoma among diabetics 
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such as the study of Lauren et al (2011) who reported that the prevalence of 
glaucoma among patients with DM was 58%. 
 
Conclusion 
 Diabetic complications are prevalent on global level and in our 
settings which implies that the therapeutic options of DM are still far from 
their ultimate goals.  
 
Recommendations  
 In view of the present findings and those shared on global level, we 
recommend adopting of more effective monitoring systems for screening 
diabetics, particularly those who are expected to develop diabetes. We also 
recommend to activate the roles of clinical pharmacist to raise the awareness 
level about diabetic complications among the public. 
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